Silverarc Capital Management »

Abivax SA F shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.0M 456k 13.22
2024-03-31 $1.1M 75k 14.30

More positions owned by Silverarc Capital Management

Merus N V (MRUS)
Nuvalent Inc-a (NUVL)
Avidity Biosciences Ord (RNA)
Urogen Pharma (URGN)
Erasca (ERAS)
Insmed Call Call Option
Morphic Hldg (MORF)
Akero Therapeutics (AKRO)
Celldex Therapeutics Com New (CLDX)
Intra Cellular Therapies (ITCI)
Poseida Therapeutics I (PSTX)
Cogent Biosciences (COGT)
Insmed Com Par $.01 (INSM)
Alnylam Pharmaceuticals (ALNY)
Elutia Cl A Com (ELUT)

View all positions for Silverarc Capital Management

Top funds holding Abivax SA F

TCG Crossover Management
Deep Track Capital
Dr. Jeffrey R. Jay, M.D.
Cormorant Asset Management
Blackstone Group
Franklin Resources
VR Adviser
Commodore Capital
Henderson Group
Nantahala Capital Management
Samsara BioCapital
Saturn V Capital Management
Morgan Stanley
Silverarc Capital Management
Citadel Advisors

View all funds holding Abivax SA F